Replies to post #164975 on Biotech Values

[DewDiligence]

VRX* acquires SLTM for $2.92/sh in cash:

http://finance.yahoo.com/news/valeant-pharmaceuticals-agrees-acquire-solta-130000891.html

The nominal deal value is $236M, and the buyout price is a 40% premium to Friday’s close.

SLTM has a motley collection of medical devices for cosmetic applications, including the Thermage radio-frequency system for skin tightening (originally owned by THRM) and the Lipisonix “body contouring” system (originally owned by MRX).

*The preeminent biotech “roll-up” company.